Zobrazeno 1 - 10
of 17
pro vyhledávání: '"C Martin Tammemagi"'
Autor:
Pamela M McMahon, Rafael Meza, Sylvia K Plevritis, William C Black, C Martin Tammemagi, Ayca Erdogan, Kevin ten Haaf, William Hazelton, Theodore R Holford, Jihyoun Jeon, Lauren Clarke, Chung Yin Kong, Sung Eun Choi, Vidit N Munshi, Summer S Han, Joost van Rosmalen, Paul F Pinsky, Suresh Moolgavkar, Harry J de Koning, Eric J Feuer
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99978 (2014)
The National Lung Screening Trial (NLST) demonstrated that in current and former smokers aged 55 to 74 years, with at least 30 pack-years of cigarette smoking history and who had quit smoking no more than 15 years ago, 3 annual computed tomography (C
Externí odkaz:
https://doaj.org/article/d70d02b354fd43f7910291de3e18de97
Autor:
Mohsen Sadatsafavi, S. F. Paul Man, John E. Connett, Raymond T. Ng, C. Martin Tammemagi, Don D. Sin, Rahman Khakban, Donald P. Tashkin, Judith M. Vonk, Zsuszanna Hollander, Stirling Bryan, Zafar Zafari, Robert A. Wise, Stephen Lam, Dirkje S. Postma, Claes-Göran Löfdahl, Bruce M. McManus
Publikováno v:
Canadian Medical Association Journal, 188(14), 1004-1011. CMA-CANADIAN MEDICAL ASSOC
Background: The rate of lung-function decline in chronic obstructive pulmonary disease (COPD) varies substantially among individuals. We sought to develop and validate an individualized prediction model for forced expiratory volume at 1 second (FEV1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0356288c3ab2e8110a1ee33e5a7f8464
https://doi.org/10.1503/cmaj.151483
https://doi.org/10.1503/cmaj.151483
Autor:
C. Martin Tammemagi, Ayumu Taguchi, Ziding Feng, Stephen Lam, Don D. Sin, Xiaobo Duan, Heidi Auman, Gary E. Goodman, Matt J. Barnett, Anthony Tam, Samir M. Hanash
Publikováno v:
Journal of Clinical Oncology. 31:4536-4543
Purpose Preliminary studies have identified pro–surfactant protein B (pro-SFTPB) to be a promising blood biomarker for non–small-cell lung cancer. We conducted a study to determine the independent predictive potential of pro-SFTPB in identifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80cb74031eb9f676d84fbd85f9f55c27
https://doi.org/10.1200/jco.2013.50.6105
https://doi.org/10.1200/jco.2013.50.6105
Autor:
Paul F. Pinsky, Martin M. Oken, John Commins, C. Martin Tammemagi, Thomas L. Riley, Neil E. Caporaso, Timothy R. Church, William G. Hocking, Paul A. Kvale, Philip C. Prorok, Christine D. Berg
Publikováno v:
JNCI: Journal of the National Cancer Institute. 103:1058-1068
Identification of individuals at high risk for lung cancer should be of value to individuals, patients, clinicians, and researchers. Existing prediction models have only modest capabilities to classify persons at risk accurately.Prospective data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ca70bb6139b64f899a985a864d60b79
https://doi.org/10.1093/jnci/djr173
https://doi.org/10.1093/jnci/djr173
Autor:
Paul Burrowes, Lori Stewart, Garth Nicholas, C. Martin Tammemagi, Frances A. Shepherd, Michael R. Johnston, Jean M. Seely, Stephen Lam, Rick Bhatia, Michel Gingras, Alain Tremblay, Janice M. Leung, Glenwood D. Goss, Daria Manos, John R. Goffin, John R. Mayo, Don D. Sin, Sergio Pasian, Ming-Sound Tsao, Geoffrey Liu, Heidi C. Roberts, Wan C. Tan, Francis Laberge, Stuart Peacock, Simon Martel
Publikováno v:
The European respiratory journal. 45(4)
Plasma pro-surfactant protein B (pro-SFTPB) levels have recently been shown to predict the development of lung cancer in current and ex-smokers, but the ability of pro-SFTPB to predict measures of chronic obstructive pulmonary disease (COPD) severity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfea6bcfdf08a52ff91a2995244e4e1
https://pubmed.ncbi.nlm.nih.gov/27581417
https://pubmed.ncbi.nlm.nih.gov/27581417
Publikováno v:
Journal of Clinical Epidemiology. 57:597-609
Objective This study evaluates the relationship between sociodemographic/exposure factors and comorbidity, and their impact on lung cancer treatment and survival. Study and design setting Data for 1,155 patients were abstracted from the Josephine For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0b10f9a06eecfe21b334c2b21a76bc
https://doi.org/10.1016/j.jclinepi.2003.11.002
https://doi.org/10.1016/j.jclinepi.2003.11.002
Publikováno v:
Cancer. 101:1655-1663
BACKGROUND The extent of disease in patients with lung carcinoma is reflected morphologically by stage and pathophysiologically by sign/symptoms. This study evaluates the associations between symptoms and stage, the independent impact of symptoms on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be8b8231f1975cdd92494046e01566f
https://doi.org/10.1002/cncr.20547
https://doi.org/10.1002/cncr.20547
Publikováno v:
Chest. 125:27-37
Study objectives Numerous studies indicate that smoking is associated with poorer outcomes in patients with cancer. The aim of this study was to determine whether smoking independently predicts survival in patients with lung cancer or whether an exis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00f493e0fa31563e42f5418900452061
https://doi.org/10.1378/chest.125.1.27
https://doi.org/10.1378/chest.125.1.27
Autor:
Suresh H. Moolgavkar, Rafael Meza, Pamela M. McMahon, Ayca Erdogan, Joost van Rosmalen, Kevin ten Haaf, C. Martin Tammemagi, Lauren Clarke, Sung Eun Choi, Paul F. Pinsky, Eric J. Feuer, Summer S. Han, Harry J. de Koning, Vidit Munshi, Chung Yin Kong, William D. Hazelton, Sylvia K. Plevritis, Theodore R. Holford, Jihyoun Jeon, William C. Black
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99978 (2014)
PLoS One (print), 9(6). Public Library of Science
PLoS ONE
PLoS One (print), 9(6). Public Library of Science
PLoS ONE
Background. The National Lung Screening Trial (NLST) demonstrated that in current and former smokers aged 55 to 74 years, with at least 30 pack-years of cigarette smoking history and who had quit smoking no more than 15 years ago, 3 annual computed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7b62a6152f76f1783447d950507c92
https://doi.org/10.1371/journal.pone.0099978
https://doi.org/10.1371/journal.pone.0099978
Autor:
Paul A. Kvale, Philip C. Prorok, Thomas L. Riley, Lawrence R. Ragard, Christine D. Berg, Ping Hu, William G. Hocking, Timothy R. Church, Martin M. Oken, C. Martin Tammemagi, Matthew T. Freedman
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(10)
Background: Some non–small cell lung cancers (NSCLC) progress to distant lymph nodes or metastasize while relatively small. Such small aggressive NSCLCs (SA-NSCLC) are no longer resectable with curative intent, carry a grave prognosis, and may invo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd6f2528beb76e922011b7b55b996be6
https://pubmed.ncbi.nlm.nih.gov/17932357
https://pubmed.ncbi.nlm.nih.gov/17932357